José M. Gatell

4.5k total citations
43 papers, 2.3k citations indexed

About

José M. Gatell is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, José M. Gatell has authored 43 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 22 papers in Epidemiology and 14 papers in Virology. Recurrent topics in José M. Gatell's work include HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (13 papers). José M. Gatell is often cited by papers focused on HIV/AIDS drug development and treatment (18 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (13 papers). José M. Gatell collaborates with scholars based in Spain, United States and Switzerland. José M. Gatell's co-authors include Estebán Martínez, Ana del Rı́o, Andrew Phillips, Francesc Marco, Amanda Mocroft, José Mallolas, Asunción Moreno, Miguel A García-Viejo, Jordi Blanch and José M. Miró and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Clinical Infectious Diseases.

In The Last Decade

José M. Gatell

43 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José M. Gatell Spain	28	1.5k	933	827	573	321	43	2.3k
Gitte Pedersen Denmark	26	1.5k 1.0×	1.1k 1.2×	708 0.9×	1.0k 1.8×	207 0.6×	89	2.8k
Renaud Verdon France	26	1.4k 0.9×	735 0.8×	500 0.6×	285 0.5×	168 0.5×	111	2.4k
Luigia Elzi Switzerland	33	2.0k 1.4×	1.1k 1.2×	817 1.0×	844 1.5×	193 0.6×	101	3.5k
Kenneth Lichtenstein United States	24	1.7k 1.2×	1.1k 1.2×	1.0k 1.2×	1.2k 2.2×	368 1.1×	39	3.2k
H. Portier France	29	1.4k 1.0×	1.2k 1.3×	494 0.6×	519 0.9×	304 0.9×	112	2.6k
Antonio Di Biagio Italy	26	1.7k 1.1×	695 0.7×	984 1.2×	709 1.2×	103 0.3×	263	2.8k
Daniel Vittecoq France	33	1.9k 1.3×	1.2k 1.2×	1.2k 1.4×	863 1.5×	108 0.3×	144	3.6k
Robert C. Kalayjian United States	30	1.5k 1.0×	1.1k 1.2×	937 1.1×	1.2k 2.1×	95 0.3×	82	3.6k
É. Bonnet France	22	739 0.5×	634 0.7×	407 0.5×	381 0.7×	168 0.5×	89	1.7k
Juan Sierra‐Madero Mexico	27	1.0k 0.7×	1.0k 1.1×	506 0.6×	308 0.5×	312 1.0×	116	2.3k

Countries citing papers authored by José M. Gatell

Since Specialization

Citations

This map shows the geographic impact of José M. Gatell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José M. Gatell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José M. Gatell more than expected).

Fields of papers citing papers by José M. Gatell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José M. Gatell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José M. Gatell. The network helps show where José M. Gatell may publish in the future.

Co-authorship network of co-authors of José M. Gatell

This figure shows the co-authorship network connecting the top 25 collaborators of José M. Gatell. A scholar is included among the top collaborators of José M. Gatell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José M. Gatell. José M. Gatell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gómara, María J., et al.. (2016). Definition of an 18-mer Synthetic Peptide Derived from the GB virus C E1 Protein as a New HIV-1 Entry Inhibitor. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(6). 1139–1148. 22 indexed citations

Rı́o, Ana del, C. García-de-la-Mària, José M. Entenza, et al.. (2015). Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 60(1). 478–486. 27 indexed citations

Manzardo, Christian, Alberto C. Guardo, Emílio Letang, et al.. (2015). Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review. Expert Review of Anti-infective Therapy. 13(6). 751–767. 49 indexed citations

Pericàs, Juan M., Carlos Cervera, Ana del Rı́o, et al.. (2014). Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clinical Microbiology and Infection. 20(12). O1075–O1083. 66 indexed citations

Manzardo, Christian, Montserrat Tuset, José M. Miró, & José M. Gatell. (2014). Interacciones graves o potencialmente letales entre antirretrovirales y otros medicamentos. Enfermedades Infecciosas y Microbiología Clínica. 33(7). e15–e30. 9 indexed citations

Álvarez-Martínez, Miriam J., José M. Miró, María Eugenia Valls, et al.. (2010). Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1–infected patients. Diagnostic Microbiology and Infectious Disease. 68(1). 60–65. 14 indexed citations

Miró, J. M., C. García-de-la-Mària, Yolanda Armero, et al.. (2009). Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(10). 4172–4177. 47 indexed citations

Marco, Francesc, Cristina García de la Mària, Yolanda Armero, et al.. (2008). Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 52(7). 2538–2543. 44 indexed citations

Martínez, Estebán, María Larrousse, & José M. Gatell. (2008). Cardiovascular disease and HIV infection: host, virus, or drugs?. Current Opinion in Infectious Diseases. 22(1). 28–34. 38 indexed citations

10.

Libois, Agnès, Christoph Stephan, Bénédicte Poll, et al.. (2006). HIV and Syphilis: When to Perform a Lumbar Puncture. Sexually Transmitted Diseases. 34(3). 141–144. 113 indexed citations

11.

Martínez, Estebán, Peré Domingo, Marı́a José Galindo, et al.. (2004). Risk of Metabolic Abnormalities in Patients Infected with HIV Receiving Antiretroviral Therapy that Contains Lopinavir‐Ritonavir. Clinical Infectious Diseases. 38(7). 1017–1023. 62 indexed citations

12.

Ferrer, Elena, Daniel Podzamczer, Mireia Arnedo, et al.. (2003). Genotype and Phenotype at Baseline and at Failure in Human Immunodeficiency Virus–Infected Antiretroviral‐Naive Patients in a Randomized Trial Comparing Zidovudine and Lamivudine plus Nelfinavir or Nevirapine. The Journal of Infectious Diseases. 187(4). 687–690. 26 indexed citations

13.

Miró, José M., Ana del Rı́o, Felipe García, et al.. (2003). Infective endocarditis not related to intravenous drug abuse in HIV-1-infected patients: report of eight cases and review of the literature. Clinical Microbiology and Infection. 9(1). 45–54. 32 indexed citations

14.

Rubio, Rafael, Juan Berenguer, José M. Miró, et al.. (2002). Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el virus de la inmunodeficiencia humana en el año 2002. Enfermedades Infecciosas y Microbiología Clínica. 20(6). 244–303. 38 indexed citations

15.

Martínez, Estebán, Amanda Mocroft, Miguel A García-Viejo, et al.. (2001). Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. The Lancet. 357(9256). 592–598. 347 indexed citations

16.

Martínez, Estebán & José M. Gatell. (1999). Metabolic abnormalities and body fat redistribution in HIV-1 infected patients: the lipodystrophy syndrome. Current Opinion in Infectious Diseases. 12(1). 13–19. 41 indexed citations

17.

Boucher, Charles A., Françoise Brun‐Vézinet, Véronique Joly, et al.. (1999). Efficacy and safety of combination therapy with delavirdine and zidovudine: a European/Australian phase II trial. International Journal of Antimicrobial Agents. 11(1). 13–21. 8 indexed citations

18.

Cooper, David A., José M. Gatell, Susanne Kroon, et al.. (1993). Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter. New England Journal of Medicine. 329(5). 297–303. 161 indexed citations

19.

Gatell, José M., et al.. (1992). Infecciones pulmonares en los pacientes con síndrome de inmunodeficiencia adquirida. Archivos de Bronconeumología. 28(1). 32–38. 2 indexed citations

20.

Bisbe, Josep, José M. Gatell, Josep Mallolas, et al.. (1988). Pseudomonas aeruginosa Bacteremia: Univariate and Multivariate Analyses of Factors Influencing the Prognosis in 133 Episodes. Clinical Infectious Diseases. 10(3). 629–635. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact